Ohio Public Employees Retirement System (OPERS)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,000
Closed -$15.7K 2029
2023
Q4
$15.7K Buy
+3,000
New +$29.6K ﹤0.01% 1868
2023
Q1
Sell
-316
Closed -$9K 2032
2022
Q4
$9K Sell
316
-429
-58% -$13.6K ﹤0.01% 1947
2022
Q3
$20K Buy
745
+283
+61% +$10.4K ﹤0.01% 2005
2022
Q2
$21K Buy
462
+222
+93% +$10.2K ﹤0.01% 1949
2022
Q1
$12K Buy
+240
New +$11.5K ﹤0.01% 1977
2019
Q4
Sell
-14,423
Closed -$816K 1967
2019
Q3
$816K Buy
14,423
+6,801
+89% +$382K ﹤0.01% 1232
2019
Q2
$424K Sell
7,622
-738
-9% -$38.5K ﹤0.01% 1375
2019
Q1
$422K Hold
8,360
﹤0.01% 1399
2018
Q4
$337K Buy
8,360
+6,738
+415% +$347K ﹤0.01% 1354
2018
Q3
$112K Buy
+1,622
New +$123K ﹤0.01% 1594
2018
Q2
Sell
-8,308
Closed -$438K 1913
2018
Q1
$438K Buy
8,308
+128
+2% +$7.44K ﹤0.01% 1411
2017
Q4
$437K Buy
+8,180
New +$455K ﹤0.01% 1403
2017
Q3
Sell
-8,243
Closed -$650K 1876
2017
Q2
$650K Buy
+8,243
New +$674K ﹤0.01% 1295

Other funds holding EGRX

Ohio Public Employees Retirement System (OPERS)'s EGRX Position: Q1 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2024, closing a stake of 3,000 shares — an estimated $15.7K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in EGRX in Q2 2017 and held it in 13 quarters. The position peaked at $816K in Q3 2019. 91 funds tracked by Wall St. Rank hold EGRX as of Q1 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 3,000 Eagle Pharmaceuticals, Inc. shares in Q1 2024, an estimated $15.7K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2017 and held it in 13 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Eagle Pharmaceuticals, Inc. position peaked at $816K in Q3 2019.
  • 91 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2024, filed 15 May 2024.